OpenAlex
PricingAboutJobs
Log inGet started
Work

Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy

HTML

Year: 2019
Type: review
Source: Journal of Cellular Physiology
DOI: 10.1002/jcp.28967
Authors: Sajad Yaghoubi, Mohammad Hossein Karimi, Majid Lotfinia, Tohid Gharibi, Motahare Mahi‐Birjand, Esmaeil Kavi, Fahimeh Hosseini, Koushan Sineh Sepehr, Mehrdad Khatami, Nader Bagheri, Meghdad Abdollahpour‐Alitappeh
Institutions: Iranshahr University, Shiraz University of Medical Sciences, Kashan University of Medical Sciences, Tabriz University of Medical Sciences, Birjand University of Medical Sciences, University of Larestan, Shahid Beheshti University, Shahid Beheshti University of Medical Sciences, Golestan University of Medical Sciences, Bam University of Medical Sciences, Shahrekord University of Medical Sciences
Language: English

Topic: Monoclonal and Polyclonal Antibodies Research
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: antibody-drug conjugates, cytotoxic payloads, small molecule drugs, drug conjugation, multidrug resistance, tumor cell internalization, clinical trials
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2950613960
FWCI: 1.562
Cites: 222
Cited by: 164
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security